1 To address how interactions between four key TFs contribute t
2 To address the challenges unique to this age group, novel str
3 To address the issue of patient stratification for immune che
4 To address the sensitivity issue, we have developed a generic
5 To address these challenges, we show that Escherichia coli En
6 To address these issues, the PhysioNet/Computing in Cardiolog
7 To address these issues, we exposed Moina dubia to lead (Pb,
8 To address these needs, we developed BrainIAK (brainiak.org),
9 To address these questions, we performed 16S sequencing on fe
10 To address this bottleneck, we combine automated sample prepa
11 To address this challenge, here we present an enzymatic metho
12 To address this crisis, we designed and executed an innovativ
13 To address this disconnect, inhibitors bearing two pharmacoph
14 To address this formidable challenge, we developed a supramol
15 To address this gap, here we developed a transgenic mouse ove
16 To address this gap, we adapted an infant mouse model of pneu
17 To address this gap, we performed whole-exome sequencing in 5
18 To address this issue, we established an experimental pipelin
19 To address this issue, we followed the antigen-specific proge
20 To address this issue, we have developed a new platform-TeSS-
21 To address this issue, we inflicted substantial DG-specific d
22 To address this issue, we propose that communities of 'rigor
23 To address this issue, we studied auditory nerve synapses ont
24 To address this knowledge gap, we investigated dissipation ha
25 To address this limitation, here we overexpressed, purified,
26 To address this need, we systematically assess methods for re
27 To address this problem, we describe a diversity of approache
28 To address this problem, we designed a sensing platform based
29 To address this problem, we generalized such models by adopti
30 To address this question empirically, we bridged art theory a
31 To address this question, we collected hours of functional ma
32 To address this question, we conducted two functional MRI exp
33 To address this question, we developed a polymeric-based cons
34 To address this question, we have expanded the toolbox of For
35 To address this question, we investigated neural and inflamma
36 To address this question, we modified a regulatable fluoresce
37 To address this question, we perform benchmark studies on sim
38 To address this question, we recorded from LSO neurons in sli
39 To address this question, we study a minimal but generic mode
40 To address this question, we used a combination of viral shRN
41 To address this situation, we previously quantified interacti
42 To address this, it is imperative we understand transmission
43 To address this, we develop Cyclum, an autoencoder approach i
44 To address this, we developed a new toolkit called HemoSYS fo
45 To address this, we have assembled a genome-scale collection
46 To address this, we here develop a generally applicable metho
47 To address this, we performed enhanced ultraviolet (UV) cross
48 To address this, we propose a general computational framework
49 To address this, we propose a new concept: allowing nonprofes
50 To address this, we use Drosophila border cell migration, an